QCM
MRNA icon

QRG Capital Management’s Moderna MRNA Stock Holding History

QRG Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$694K Buy
+13,666
New +$638K 0.01% 679
2025
Q2 		– Sell
-8,274
Closed -$235K – 1145
2025
Q1 		$235K Buy
8,274
+1,150
+16% +$40.8K ﹤0.01% 975
2024
Q4 		$296K Sell
7,124
-8,666
-55% -$414K ﹤0.01% 907
2024
Q3 		$1.06M Sell
15,790
-20,037
-56% -$1.84M 0.01% 578
2024
Q2 		$4.25M Sell
35,827
-708
-2% -$89.6K 0.05% 294
2024
Q1 		$3.89M Sell
36,535
-28,220
-44% -$2.84M 0.05% 306
2023
Q4 		$6.44M Buy
64,755
+672
+1% +$56.5K 0.1% 219
2023
Q3 		$6.62M Buy
+64,083
New +$7.15M 0.11% 194

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return